Localized pure or mixed ground-glass lung opacities;Opacités pulmonaires localisées partiellement ou totalement en verre dépoli

Journal de Radiologie

Volumn 90, Issue 11 C2, 2009, Pages 1869-1892

  Felix L ^a   Lantuejoul, S ^a,b   Jankowski, A ^a,b   Ferretti, G ^a,b  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

^b INSERM   (France)

Author keywords

Chest; Computed tomography; Ground glass opacity; Lung

Indexed keywords

COMPUTER ASSISTED TOMOGRAPHY; EARLY CANCER; FIBROSING ALVEOLITIS; GROUND GLASS LUNG OPACITY; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HYPERPLASIA; INFECTION; INFLAMMATORY DISEASE; LUNG ADENOCARCINOMA; LUNG ALVEOLUS CELL CARCINOMA; LUNG ALVEOLUS WALL; LUNG CANCER; LUNG DISEASE; LUNG NODULE; METASTASIS; MOLECULAR BIOLOGY; PREVALENCE; PROGNOSIS; REVIEW; SCREENING; ADENOCARCINOMA; ALGORITHM; BIOPSY; CANCER STAGING; CASE REPORT; CLASSIFICATION; CLINICAL TRIAL; COMPARATIVE STUDY; DIFFERENTIAL DIAGNOSIS; FEMALE; LUNG; LUNG ALVEOLUS; LUNG TUMOR; METHODOLOGY; MIDDLE AGED; PATHOLOGY; RADIOGRAPHY; RISK FACTOR; SMOKING; THORAX RADIOGRAPHY;

ADENOCARCINOMA; ADENOCARCINOMA, BRONCHIOLO-ALVEOLAR; ALGORITHMS; BIOPSY; CLINICAL TRIALS AS TOPIC; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; HYPERPLASIA; LUNG; LUNG NEOPLASMS; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PULMONARY ALVEOLI; RADIOGRAPHY, THORACIC; RISK FACTORS; SMOKING; SOLITARY PULMONARY NODULE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 74049089010     PISSN: 02210363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0221-0363(09)73289-5     Document Type: Article

References (101)

1. Kaneko M, Eguchi K, Ohmatsu H, Kakinuma R, Naruke T, Suemasu K et al. Peripheral lung cancer: screening and detection with low-dose spiral CT versus radiography. Radiology 1996;201:798-802.
2. Henschke CI, McCauley DI, Yankelevitz DF, Naidich DP, McGuinness G, Miettinen OS et al. Early Lung Cancer Action Project: overall design and findings from baseline screening. Lancet 1999;354:99-105.
3. Beigelman-Aubry C, Hill C, Grenier PA. Management of an incidentally discovered pulmonary nodule. Eur Radiol 2007;17:449-66.
4. Hansell DM, Bankier AA, MacMahon H, McLoud TC, Muller NL, Remy J. Fleischner Society: glossary of terms for thoracic imaging. Radiology 2008;246:697-722.
5. Nakajima R, Yokose T, Kakinuma R, Nagai K, Nishiwaki Y, Ochiai A. Localized pure ground-glass opacity on high-resolution CT: histologic characteristics. J Comput Assist Tomogr 2002;26: 323-9.
6. Yang ZG, Sone S, Takashima S, Li F, Honda T, Maruyama Y et al. High-resolution CT analysis of small peripheral lung adenocarcinomas revealed on screening helical CT. AJR Am J Roentgenol 2001;176:1399-407.
7. Li F, Sone S, Abe H, Macmahon H, Doi K. Malignant versus benign nodules at CT screening for lung cancer: comparison of thin-section CT findings. Radiology 2004;233:793-8.
8. Nakazono T, Sakao Y, Yamaguchi K, Imai S, Kumazoe H, Kudo S. Subtypes of peripheral adenocarcinoma of the lung: differentiation by thin-section CT. Eur Radiol 2005;15:1563-8.
9. Lee HJ, Goo JM, Lee CH, Yoo CG, Kim YT, Im JG. Nodular ground-glass opacities on thin-section CT: size change during follow-up and pathological results. Korean J Radiol 2007;8:22-31.
10. Ko JP, Rusinek H, Naidich DP, McGuinness G, Rubinowitz AN, Leitman BS et al. Wavelet compression of low-dose chest CT data: effect on lung nodule detection. Radiology 2003;228:70-5.
11. Li F, Sone S, Abe H, MacMahon H, Armato SG, 3rd, Doi K. Lung cancers missed at low-dose helical CT screening in a general population: comparison of clinical, histopathologic, and imaging findings. Radiology 2002;225:673-83.
12. Collins J, Stern EJ. Ground-glass opacity at CT: the ABCs. AJR Am J Roentgenol 1997;169:355-67.
13. Valencia R, Denecke T, Lehmkuhl L, Fischbach F, Felix R, Knollmann F. Value of axial and coronal maximum intensity projection (MIP) images in the detection of pulmonary nodules by multislice spiral CT: comparison with axial 1-mm and 5-mm slices. Eur Radiol 2006;16:325-32.
14. Jankowski A, Martinelli T, Timsit JF, Brambilla C, Thony F, Coulomb M et al. Pulmonary nodule detection on MDCT images: evaluation of diagnostic performance using thin axial images, maximum intensity projections, and computer-assisted detection. Eur Radiol 2007;17:3148-56.
15. Kim KG, Goo JM, Kim JH, Lee HJ, Min BG, Bae KT et al. Computer-aided diagnosis of localized ground-glass opacity in the lung at CT: initial experience. Radiology 2005;237:657-61.
16. Sumikawa H, Johkoh T, Nagareda T, Sekiguchi J, Matsuo K, Fujita Y et al. Pulmonary adenocarcinomas with ground-glass attenuation on thin-section CT: quantification by three-dimensional image analyzing method. Eur J Radiol 2008;65:104-11.
17. Tsubamoto M, Kuriyama K, Kido S, Arisawa J, Kohno N, Johkoh T et al. Detection of lung cancer on chest radiographs: analysis on the basis of size and extent of ground-glass opacity at thin-section CT. Radiology 2002;224:139-44.
18. Henschke CI, Yankelevitz DF, Mirtcheva R, McGuinness G, Mc-Cauley D, Miettinen OS. CT screening for lung cancer: frequency and significance of part-solid and nonsolid nodules. AJR Am J Roentgenol 2002;178:1053-7.
19. Chong S, Lee KS, Chung MJ, Kim TS, Kim H, Kwon OJ et al. Lung cancer screening with low-dose helical CT in Korea: experiences at the Samsung Medical Center. J Korean Med Sci 2005;20:402-8.
20. MacRedmond R, Logan PM, Lee M, Kenny D, Foley C, Costello RW. Screening for lung cancer using low dose CT scanning. Thorax 2004;59:237-41.
21. MacRedmond R, McVey G, Lee M, Costello RW, Kenny D, Foley C et al. Screening for lung cancer using low dose CT scanning: results of 2 year follow up. Thorax 2006;61:54-6.
22. Jang HJ, Lee KS, Kwon OJ, Rhee CH, Shim YM, Han J. Bronchioloalveolar carcinoma: focal area of ground-glass attenuation at thin-section CT as an early sign. Radiology 1996;199:485-8.
23. Nakata M, Saeki H, Takata I, Segawa Y, Mogami H, Mandai K et al. Focal ground-glass opacity detected by low-dose helical CT. Chest 2002;121:1464-7.
24. Takashima S, Sone S, Li F, Maruyama Y, Hasegawa M, Matsushita T et al. Small solitary pulmonary nodules (< or =1 cm) detected at population-based CT screening for lung cancer: Reliable highresolution CT features of benign lesions. AJR Am J Roentgenol 2003;180:955-64.
25. Noguchi M, Morikawa A, Kawasaki M, Matsuno Y, Yamada T, Hirohashi S et al. Small adenocarcinoma of the lung. Histologic characteristics and prognosis. Cancer 1995;75:2844-52.
26. Park CM, Goo JM, Lee HJ, Lee CH, Kim HC, Chung DH et al. CT findings of atypical adenomatous hyperplasia in the lung. Korean J Radiol 2006;7:80-6.
27. Kuriyama K, Seto M, Kasugai T, Higashiyama M, Kido S, Sawai Y et al. Ground-glass opacity on thin-section CT: value in differentiating subtypes of adenocarcinoma of the lung. AJR Am J Roentgenol 1999;173:465-9.
28. Kawakami S, Sone S, Takashima S, Li F, Yang ZG, Maruyama Y et al. Atypical adenomatous hyperplasia of the lung: correlation between high-resolution CT findings and histopathologic features. Eur Radiol 2001;11:811-4.
29. Nakahara R, Yokose T, Nagai K, Nishiwaki Y, Ochiai A. Atypical adenomatous hyperplasia of the lung: a clinicopathological study of 118 cases including cases with multiple atypical adenomatous hyperplasia. Thorax 2001;56:302-5.
30. Park CM, Goo JM, Lee HJ, Lee CH, Chung DH, Chun EJ et al. Focal interstitial fibrosis manifesting as nodular ground-glass opacity: thin-section CT findings. Eur Radiol 2007.
31. Park CM, Goo JM, Lee HJ, Lee CH, Chun EJ, Im JG. Nodular ground-glass opacity at thin-section CT: histologic correlation and evaluation of change at follow-up. Radiographics 2007;27:391-408.
32. Kodama K, Higashiyama M, Yokouchi H, Takami K, Kuriyama K, Kusunoki Y et al. Natural history of pure ground-glass opacity after long-term follow-up of more than 2 years. Ann Thorac Surg 2002;73:386-92; discussion 392-3.
33. Shaham D, Guralnik L. The solitary pulmonary nodule: radiologic considerations. Semin Ultrasound CT MR 2000;21:97-115.
34. Ko JP, Naidich DP. Lung nodule detection and characterization with multislice CT. Radiol Clin North Am 2003;41:575-97, vi.
35. Oh JY, Kwon SY, Yoon HI, Lee SM, Yim JJ, Lee JH et al. Clinical significance of a solitary ground-glass opacity (GGO) lesion of the lung detected by chest CT. Lung Cancer 2007;55:67-73.
36. Travis WD, Garg K, Franklin WA, Wistuba, II, Sabloff B, Noguchi M et al. Evolving concepts in the pathology and computed tomography imaging of lung adenocarcinoma and bronchioloalveolar carcinoma. J Clin Oncol 2005;23:3279-87.
37. Travis WD, Colby TV, Corrin B ea. Histological Typing of lung and pleural tumours, 3rd ed. Berlin, Springer Verlag. 1999.
38. Kitamura H, Kameda Y, Ito T, Hayashi H. Atypical adenomatous hyperplasia of the lung. Implications for the pathogenesis of peripheral lung adenocarcinoma. Am J Clin Pathol 1999;111:610-22.
39. Miller RR. Bronchioloalveolar cell adenomas. Am J Surg Pathol 1990;14:904-12.
40. Carey FA, Wallace WA, Fergusson RJ, Kerr KM, Lamb D. Alveolar atypical hyperplasia in association with primary pulmonary adenocarcinoma: a clinicopathological study of 10 cases. Thorax 1992;47:1041-3.
41. Nakanishi K. Alveolar epithelial hyperplasia and adenocarcinoma of the lung. Arch Pathol Lab Med 1990;114:363-8.
42. Weng SY, Tsuchiya E, Kasuga T, Sugano H. Incidence of atypical bronchioloalveolar cell hyperplasia of the lung: relation to histological subtypes of lung cancer. Virchows Arch A Pathol Anat Histopathol 1992;420:463-71.
43. Kerr KM. Pulmonary preinvasive neoplasia. J Clin Pathol 2001;54:257-71.
44. Noguchi M, Shimosato Y. The development and progression of adenocarcinoma of the lung. Cancer Treat Res 1995;72:131-42.
45. Suzuki K, Nagai K, Yoshida J, Yokose T, Kodama T, Takahashi K et al. The prognosis of resected lung carcinoma associated with atypical adenomatous hyperplasia: a comparison of the prognosis of well-differentiated adenocarcinoma associated with atypical adenomatous hyperplasia and intrapulmonary metastasis. Cancer 1997;79:1521-6.
46. Travis WD, Brambilla E, Müller-Hermelink HK, CC. H. Pathology and Genetics: Tumours of the Lung, Pleura, Thymus and Heart. Lyon, IARC. 2004.
47. Gandara DR, Aberle D, Lau D, Jett J, Akhurst T, Mulshine J et al. Radiographic imaging of bronchioloalveolar carcinoma: screening, patterns of presentation and response assessment. J Thorac Oncol 2006;1(9 Suppl):S20-6.
48. Wislez M, Beer DG, Wistuba I, Cadranel J, Saijo N, Johnson BE. Molecular biology, genomics, and proteomics in bronchioloalveolar carcinoma. J Thorac Oncol 2006;1(9 Suppl):S8-12.
49. Takashima S, Sone S, Li F, Maruyama Y, Hasegawa M, Kadoya M. Indeterminate solitary pulmonary nodules revealed at populationbased CT screening of the lung: using first follow-up diagnostic CT to differentiate benign and malignant lesions. AJR Am J Roentgenol 2003;180:1255-63.
50. Aoki T, Nakata H, Watanabe H, Nakamura K, Kasai T, Hashimoto H et al. Evolution of peripheral lung adenocarcinomas: CT findings correlated with histology and tumor doubling time. AJR Am J Roentgenol 2000;174:763-8.
51. Takashima S, Maruyama Y, Hasegawa M, Yamanda T, Honda T, Kadoya M et al. CT findings and progression of small peripheral lung neoplasms having a replacement growth pattern. AJR Am J Roentgenol 2003;180:817-26.
52. Vazquez MF, Flieder DB. Small peripheral glandular lesions detected by screening CT for lung cancer. A diagnostic dilemma for the pathologist. Radiol Clin North Am 2000;38:579-89.
53. Li F, Sone S, Maruyama Y, Takashima S, Yang ZG, Hasegawa M et al. Correlation between high-resolution computed tomographic, magnetic resonance and pathological findings in cases with noncancerous but suspicious lung nodules. Eur Radiol 2000;10:1782-91.
54. Nomori H, Ohtsuka T, Naruke T, Suemasu K. Differentiating between atypical adenomatous hyperplasia and bronchioloalveolar carcinoma using the computed tomography number histogram. Ann Thorac Surg 2003;76:867-71.
55. Ikeda K, Awai K, Mori T, Kawanaka K, Yamashita Y, Nomori H. Differential diagnosis of ground-glass opacity nodules: CT number analysis by three-dimensional computerized quantification. Chest 2007;132:984-90.
56. Oda S, Awai K, Liu D, Nakaura T, Yanaga Y, Nomori H et al. Ground-glass opacities on thin-section helical CT: differentiation between bronchioloalveolar carcinoma and atypical adenomatous hyperplasia. AJR Am J Roentgenol 2008;190:1363-8.
57. Lee KS, Kim Y, Han J, Ko EJ, Park CK, Primack SL. Bronchioloalveolar carcinoma: clinical, histopathologic, and radiologic findings. Radiographics 1997;17:1345-57.
58. Mihara N, Ichikado K, Johkoh T, Honda O, Higashi M, Tomiyama N et al. The subtypes of localized bronchioloalveolar carcinoma: CT-pathologic correlation in 18 cases. AJR Am J Roentgenol 1999;173:75-9.
59. Travis WD, Garg K, Franklin WA, Wistuba, II, Sabloff B, Noguchi M et al. Bronchioloalveolar carcinoma and lung adenocarcinoma: the clinical importance and research relevance of the 2004 World Health Organization pathologic criteria. J Thorac Oncol 2006;1(9 Suppl):S13-9.
60. Kodama K, Higashiyama M, Yokouchi H, Takami K, Kuriyama K, Mano M et al. Prognostic value of ground-glass opacity found in small lung adenocarcinoma on high-resolution CT scanning. Lung Cancer 2001;33:17-25.
61. Hara M, Oda K, Ogino H, Oshima H, Sato Y, Kiriyama M et al. Focal fibrosis as a cause of localized ground glass attenuation (GGA) - CT and MR findings. Radiat Med 2002;20:93-5.
62. Yoshida J, Nagai K, Yokose T, Nishimura M, Kakinuma R, Ohmatsu H et al. Limited resection trial for pulmonary ground-glass opacity nodules: fifty-case experience. J Thorac Cardiovasc Surg 2005;129:991-6.
63. Nambu A, Araki T, Taguchi Y, Ozawa K, Miyata K, Miyazawa M et al. Focal area of ground-glass opacity and ground-glass opacity predominance on thin-section CT: discrimination between neoplastic and non-neoplastic lesions. Clin Radiol 2005;60:1006-17.
64. Terasaki H, Niki T, Matsuno Y, Yamada T, Maeshima A, Asamura H et al. Lung adenocarcinoma with mixed bronchioloalveolar and invasive components: clinicopathological features, subclassification by extent of invasive foci, and immunohistochemical characterization. Am J Surg Pathol 2003;27:937-51.
65. Suzuki K, Yokose T, Yoshida J, Nishimura M, Takahashi K, Nagai K et al. Prognostic significance of the size of central fibrosis in peripheral adenocarcinoma of the lung. Ann Thorac Surg 2000;69: 893-7.
66. Yokose T, Suzuki K, Nagai K, Nishiwaki Y, Sasaki S, Ochiai A. Favorable and unfavorable morphological prognostic factors in peripheral adenocarcinoma of the lung 3 cm or less in diameter. Lung Cancer 2000;29:179-88.
67. Sakurai H, Maeshima A, Watanabe S, Suzuki K, Tsuchiya R, Maeshima AM et al. Grade of stromal invasion in small adenocarcinoma of the lung: histopathological minimal invasion and prognosis. Am J Surg Pathol 2004;28:198-206.
68. Kim EA, Johkoh T, Lee KS, Han J, Fujimoto K, Sadohara J et al. Quantification of ground-glass opacity on high-resolution CT of small peripheral adenocarcinoma of the lung: pathologic and prognostic implications. AJR Am J Roentgenol 2001;177:1417-22.
69. Takashima S, Maruyama Y, Hasegawa M, Saito A, Haniuda M, Kadoya M. High-resolution CT features: prognostic significance in peripheral lung adenocarcinoma with bronchioloalveolar carcinoma components. Respiration 2003;70:36-42.
70. Shimizu K, Yamada K, Saito H, Noda K, Nakayama H, Kameda Y et al. Surgically curable peripheral lung carcinoma: correlation of thin-section CT findings with histologic prognostic factors and survival. Chest 2005;127:871-8.
71. Takashima S, Li F, Maruyama Y, Hasegawa M, Takayama F, Kadoya M et al. Discrimination of subtypes of small adenocarcinoma in the lung with thin-section CT. Lung Cancer 2002;36:175-82.
72. Aoki T, Tomoda Y, Watanabe H, Nakata H, Kasai T, Hashimoto H et al. Peripheral lung adenocarcinoma: correlation of thin-section CT findings with histologic prognostic factors and survival. Radiology 2001;220:803-9.
73. Okada M, Nishio W, Sakamoto T, Uchino K, Hanioka K, Ohbayashi C et al. Correlation between computed tomographic findings, bronchioloalveolar carcinoma component, and biologic behavior of small-sized lung adenocarcinomas. J Thorac Cardiovasc Surg 2004;127:857-61.
74. Matsuguma H, Yokoi K, Anraku M, Kondo T, Kamiyama Y, Mori K et al. Proportion of ground-glass opacity on high-resolution computed tomography in clinical T1 N0 M0 adenocarcinoma of the lung: A predictor of lymph node metastasis. J Thorac Cardiovasc Surg 2002;124:278-84.
75. Kurokawa T, Matsuno Y, Noguchi M, Mizuno S, Shimosato Y. Surgically curable 'early' adenocarcinoma in the periphery of the lung. Am J Surg Pathol 1994;18:431-8.
76. Nagao M, Murase K, Yasuhara Y, Ikezoe J, Eguchi K, Mogami H et al. Measurement of localized ground-glass attenuation on thin-section computed tomography images: correlation with the progression of bronchioloalveolar carcinoma of the lung. Invest Radiol 2002;37:692-7.
77. Takashima S, Maruyama Y, Hasegawa M, Yamanda T, Honda T, Kadoya M et al. Prognostic significance of high-resolution CT findings in small peripheral adenocarcinoma of the lung: a retrospective study on 64 patients. Lung Cancer 2002;36:289-95.
78. Erasmus JJ, Connolly JE, McAdams HP, Roggli VL. Solitary pulmonary nodules: Part I. Morphologic evaluation for differentiation of benign and malignant lesions. Radiographics 2000;20:43-58.
79. Erasmus JJ, McAdams HP, Connolly JE. Solitary pulmonary nodules: Part II. Evaluation of the indeterminate nodule. Radiographics 2000;20:59-66.
80. Kim HY, Shim YM, Lee KS, Han J, Yi CA, Kim YK. Persistent pulmonary nodular ground-glass opacity at thin-section CT: histopathologic comparisons. Radiology 2007;245:267-75.
81. Nakata M, Sawada S, Saeki H, Takashima S, Mogami H, Teramoto N et al. Prospective study of thoracoscopic limited resection for ground-glass opacity selected by computed tomography. Ann Thorac Surg 2003;75:1601-5; discussion 1605-6.
82. Nakamura H, Saji H, Ogata A, Saijo T, Okada S, Kato H. Lung cancer patients showing pure ground-glass opacity on computed tomography are good candidates for wedge resection. Lung Cancer 2004;44:61-8.
83. Watanabe S, Watanabe T, Arai K, Kasai T, Haratake J, Urayama H. Results of wedge resection for focal bronchioloalveolar carcinoma showing pure ground-glass attenuation on computed tomography. Ann Thorac Surg 2002;73:1071-5.
84. Asamura H, Suzuki K, Watanabe S, Matsuno Y, Maeshima A, Tsuchiya R. A clinicopathological study of resected subcentimeter lung cancers: a favorable prognosis for ground glass opacity lesions. Ann Thorac Surg 2003;76:1016-22.
85. Rusch VW, Tsuchiya R, Tsuboi M, Pass HI, Grunenwald D, Goldstraw P. Surgery for bronchioloalveolar carcinoma and 'very early' adenocarcinoma: an evolving standard of care? J Thorac Oncol 2006;1(9 Suppl):S27-31.
86. Ohta Y, Oda M, Wu J, Tsunezuka Y, Hiroshi M, Nonomura A et al. Can tumor size be a guide for limited surgical intervention in patients with peripheral non-small cell lung cancer? Assessment from the point of view of nodal micrometastasis. J Thorac Cardiovasc Surg 2001;122:900-6.
87. Sequist LV, Bell DW, Lynch TJ, Haber DA. Molecular predictors of response to epidermal growth factor receptor antagonists in nonsmall-cell lung cancer. J Clin Oncol 2007;25:587-95.
88. Kakinuma R, Ohmatsu H, Kaneko M, Kusumoto M, Yoshida J, Nagai K et al. Progression of focal pure ground-glass opacity detected by low-dose helical computed tomography screening for lung cancer. J Comput Assist Tomogr 2004;28:17-23.
89. Yankelevitz DF, Reeves AP, Kostis WJ, Zhao B, Henschke CI. Small pulmonary nodules: volumetrically determined growth rates based on CT evaluation. Radiology 2000;217:251-6.
90. Hasegawa M, Sone S, Takashima S, Li F, Yang ZG, Maruyama Y et al. Growth rate of small lung cancers detected on mass CT screening. Br J Radiol 2000;73:1252-9.
91. Yankelevitz DF, Henschke CI. Does 2-year stability imply that pulmonary nodules are benign? AJR Am J Roentgenol 1997; 168:325-8.
92. MacMahon H, Austin JH, Gamsu G, Herold CJ, Jett JR, Naidich DP et al. Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner Society. Radiology 2005;237:395-400.
93. Swensen SJ, Viggiano RW, Midthun DE, Muller NL, Sherrick A, Yamashita K et al. Lung nodule enhancement at CT: multicenter study. Radiology 2000;214:73-80.
94. Rohren EM, Turkington TG, Coleman RE. Clinical applications of PET in oncology. Radiology 2004;231:305-32.
95. Gould MK, Maclean CC, Kuschner WG, Rydzak CE, Owens DK. Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis. Jama 2001;285:914- 24.
96. Nomori H, Watanabe K, Ohtsuka T, Naruke T, Suemasu K, Uno K. Evaluation of F-18 fluorodeoxyglucose (FDG) PET scanning for pulmonary nodules less than 3 cm in diameter, with special reference to the CT images. Lung Cancer 2004;45: 19-27.
97. Nomori H, Kosaka N, Watanabe K, Ohtsuka T, Naruke T, Kobayashi T et al. 11C-acetate positron emission tomography imaging for lung adenocarcinoma 1 to 3 cm in size with ground-glass opacity images on computed tomography. Ann Thorac Surg 2005; 80:2020-5.
98. Kaji M, Nomori H, Watanabe K, Ohtsuka T, Naruke T, Suemasu K et al. 11C-acetate and 18F-fluorodeoxyglucose positron emission tomography of pulmonary adenocarcinoma. Ann Thorac Surg 2007; 83:312-4.
99. Kim TJ, Lee JH, Lee CT, Jheon SH, Sung SW, Chung JH et al. Diagnostic accuracy of CT-guided core biopsy of ground-glass opacity pulmonary lesions. AJR Am J Roentgenol 2008;190:234-9.
100. Watanabe K, Nomori H, Ohtsuka T, Kaji M, Naruke T, Suemasu K. Usefulness and complications of computed tomographyguided lipiodol marking for fluoroscopy-assisted thoracoscopic resection of small pulmonary nodules: experience with 174 nodules. J Thorac Cardiovasc Surg 2006;132:320-4.
101. Ikeda K, Nomori H, Mori T, Kobayashi H, Iwatani K, Yoshimoto K et al. Impalpable pulmonary nodules with ground-glass opacity: Success for making pathologic sections with preoperative marking by lipiodol. Chest 2007;131:502-6.